Long-Term Outcomes For Laser Vision Correction Utilising A New Topography-Integrated Wavefront Guided Aberrometer

To evaluate the long-term safety and efficacy outcomes of iDesign 2.0 in patients who underwent laser vision correction.

Private Refractive Surgery (Optical Express)

Analysed cohort consists of patients who underwent laser vision correction with iDesign 2.0 ablation and attended a clinical visit at one year postop. Clinical assessments, patient-reported outcomes, and any complications were recorded in an electronic medical record.

The total number of patients included was 130 (256 eyes), with pre-op refractive range of +2.75D to -9.75D with up to 4.75D of astigmatism.  At one year postop, 90.5% had MSE within 0.5D of emmetropia. Of these patients, 93.8% had monocular UCDVA of 6/6 or better and 100.0% had 6/12 or better; 98.5% patients had binocular UCDVA of 6/6 or better and 100% had 6/9 or better. No patients in the cohort had a loss in BCDVA of >2 lines. 96.2% of patients reported very satisfied or satisfied; 1.5% reported dissatisfied or very dissatisfied at their last assessment

Long-term follow-up demonstrates this new wavefront guided aberrometer is safe and effective. In addition to high levels of visual acuity gain, patient-reported satisfaction was also high. Incidence of complications was low and in line with other treatment formats. Long-term outcomes from a clinical and patient reported perspective are excellent.